The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 270.00
Ask: 280.00
Change: 21.00 (8.27%)
Spread: 10.00 (3.704%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 254.00
MAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Jan 2020 07:00

RNS Number : 2078Z
Maintel Holdings PLC
09 January 2020
 

Maintel Holdings Plc

Trading Update

Maintel Holdings plc (the "Group" or "Maintel") today issues the following trading update for the financial year ending 31st December 2019.

Whilst the Group has continued to make encouraging progress in its transformation to a cloud-first business, the Board, for the following reasons, now expects to report a lower level of revenue and adjusted EBITDA* than previously anticipated:

·; The protracted delay in the announcement of the new public sector procurement frameworks significantly reduced the number of available bids during the period. Whilst Maintel was awarded a number of such contracts through this channel in Q4, they were awarded too late in Q4 to deliver sufficient revenue in FY2019

·; The continued political and economic uncertainty in the run up to the December general election also resulted in delays to project implementation and the securing of new contracts

·; As a result of two of the group's partners losing four contracts between them, managed service revenue to the Group reduced faster than expected. The Board is confident that the contract renewal profile for 2020 does not represent a similar risk.

For the year ended 31st December 2019, the Board now expects revenue of approximately £123m and adjusted EBITDA of approximately £10.8m excluding IFRS 16 adjustments and approximately £11.7m including IFRS 16 adjustments.

Outlook for FY 2020

For the year ending 31st December 2020, the Board anticipates that the Group will deliver low single digit organic revenue growth, underpinned by the improved order intake in Q4 and a return to healthier levels of activity in the public sector. A current review of measures to improve margins is expected to deliver benefits in the latter part of FY2020.

Updated Dividend Policy

In recognition of the reduced profit expectations of the Group and to maintain balance sheet strength, the Board has made the decision to rebase the dividend. The Board expects to reduce the final dividend for FY 19 by 50% versus the final dividend for FY 18, to 9.8 pence per share. Off this lower base, the Board intends to maintain a progressive dividend policy in the future.

Ioan MacRae, Maintel's Chief Executive Officer, said:

"While our anticipated overall results for 2019 are disappointing, we are very encouraged by the progress against our strategic aim of becoming a cloud-first company. In FY 19 the number of contracted seats on our ICON platform grew by 25% year on year, including winning our first channel partner contract for our cloud services. An increase in public sector business coupled with a strong performance in order intake in Q4 2019 provides us with a good degree of confidence for 2020, when we expect to return to both revenue and EBITDA growth.

Less than three months into the job, despite these disappointing results, I am even more optimistic for the prospects of the Group. We have identified a number of strategic initiatives to deliver growth and margin improvements which we will look to implement over the course of this financial year. I look forward to updating shareholders with more detail on these at the time of our results which are expected to be released in late March 2020."

 

*Adjusted EBITDA is earnings before interest, tax, depreciation and amortisation, adjusted for share based payments and exceptional costs.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

For further information please contact:

 

 

Ioan MacRae, Chief Executive Officer

Mark Townsend, Chief Financial Officer

0344 871 1122

Rufus Grig, Chief Technology and Strategy Officer

 

 

finnCap (Nomad and Broker)

 

Jonny Franklin-Adams / Anthony Adams (Corporate Finance)

Richard Chambers / Sunila de Silva (Corporate Broking)

 

020 7220 0500

Oakley Advisory (Financial Advisors)

Christian Maher / Victoria Boxall

 

 

020 7766 6900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKZGGMVRVGGZM
Date   Source Headline
1st Feb 20081:50 pmRNSDirector/PDMR Shareholding
31st Jan 200811:46 amRNSTotal Voting Rights
17th Jan 20089:21 amRNSTransaction in Own Shares
3rd Jan 20083:42 pmRNSDirector/PDMR Shareholding
31st Dec 20077:00 amRNSTotal Voting Rights
10th Dec 200710:16 amRNSTransaction in Own Shares
3rd Dec 20072:16 pmRNSDirector/PDMR Shareholding
1st Nov 20079:07 amRNSDirector/PDMR Shareholding
1st Oct 20072:37 pmRNSDirector/PDMR Shareholding
10th Sep 20077:01 amRNSInterim Results
3rd Sep 200712:48 pmRNSDirector/PDMR Shareholding
8th Aug 20073:10 pmRNSAIM Rule 26
3rd Aug 200711:56 amRNSAcquisition
1st Aug 20074:27 pmRNSDirector/PDMR Shareholding
2nd Jul 200711:45 amRNSDirector/PDMR Shareholding
31st May 200712:29 pmRNSDirector/PDMR Shareholding
30th Apr 20073:27 pmRNSDirector/PDMR Shareholding
25th Apr 20073:37 pmRNSDirector/PDMR Shareholding
2nd Apr 200710:53 amRNSDirector/PDMR Shareholding
28th Mar 20073:16 pmRNSHolding(s) in Company
12th Mar 20077:01 amRNSFinal Results
1st Mar 20079:30 amRNSDirector/PDMR Shareholding
1st Feb 200712:05 pmRNSDirector/PDMR Shareholding
26th Jan 20073:59 pmRNSHolding(s) in Company
22nd Jan 20077:01 amRNSHolding(s) in Company
3rd Jan 200712:46 pmRNSDirector/PDMR Shareholding
22nd Dec 200611:40 amRNSTotal Voting Rights
30th Nov 20063:41 pmRNSDirector/PDMR Shareholding
4th Oct 20067:00 amRNSHolding(s) in Company
28th Sep 20067:01 amRNSTransaction in Own Shares
11th Sep 20067:01 amRNSTransaction in Own Shares
7th Sep 20067:01 amRNSInterim Results
20th Jun 20061:41 pmRNSHolding(s) in Company
13th Jun 200610:18 amRNSTransaction in Own Shares
12th Jun 20061:30 pmRNSAcquisition
13th Mar 20067:01 amRNSFinal Results
22nd Feb 20067:01 amRNSContract Win
10th Jan 20069:23 amRNSDirector/PDMR Shareholding
21st Dec 20052:51 pmRNSDirector/PDMR Shareholding
20th Dec 20055:07 pmRNSDirectorate Change
16th Nov 200512:35 pmRNSTransaction in Own Shares
21st Oct 20055:38 pmRNSTransaction in Own Shrs-Amend
17th Jun 20053:21 pmRNSHolding(s) in Company
25th May 20059:02 amRNSTransaction in Own Shares
4th May 20055:54 pmRNSTransaction in Own Shares
3rd May 20055:31 pmRNSTransaction in Own Shares
11th Mar 20057:00 amRNSFinal Results
19th Jan 20054:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.